Practice Variations in the Use of Novel Oral Anticoagulants for Nonvalvular Atrial Fibrillation-Related Stroke among Stroke Neurologists in Saudi Arabia

<div>Participants’ responses to the question of how many days they would further delay the initiation of NOACs if a pre-NOACs CT head shows hemorrhagic transformation (HT) of the index stroke.</div>

Neurology Research International

fig2

Figure 2

Figure 2: Practice Variations in the Use of Novel Oral Anticoagulants for Nonvalvular Atrial Fibrillation-Related Stroke among Stroke Neurologists in Saudi Arabia 

Figure 2 | Practice Variations in the Use of Novel Oral Anticoagulants for Nonvalvular Atrial Fibrillation-Related Stroke among Stroke Neurologists in Saudi Arabia 